Avinger (NASDAQ:AVGR) Receives New Coverage from Analysts at StockNews.com

StockNews.com began coverage on shares of Avinger (NASDAQ:AVGR) in a research report sent to investors on Tuesday. The firm issued a hold rating on the medical device company’s stock.

Avinger Price Performance

AVGR stock traded up $0.02 during mid-day trading on Tuesday, reaching $1.22. The company had a trading volume of 15,124 shares, compared to its average volume of 40,796. Avinger has a 52 week low of $1.11 and a 52 week high of $14.00. The company has a market capitalization of $2.07 million, a price-to-earnings ratio of -0.07 and a beta of 1.26. The stock has a 50 day simple moving average of $1.70 and a two-hundred day simple moving average of $2.74.

Avinger (NASDAQ:AVGR) last released its earnings results on Thursday, August 8th. The medical device company reported ($2.82) earnings per share for the quarter, missing the consensus estimate of ($0.43) by ($2.39). The company had revenue of $1.85 million for the quarter, compared to analyst estimates of $2.55 million. On average, equities analysts predict that Avinger will post -2.08 EPS for the current year.

Avinger Company Profile

Avinger, Inc, a commercial-stage medical device company, designs, manufactures, and sells a suite of image-guided and catheter-based systems used by physicians to treat patients with peripheral artery disease (PAD) primarily in the United States and Germany. The company develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures.